Two-year clinical data show positive functionality of Xeltis’ bioabsorbable cardiovascular device
Xeltis announced that patients implanted with its bioabsorbable cardiovascular conduit showed positive functionality results two years after surgery. The data have been presented at the 30th European Association for Cardio-Thoracic Surgery (EACTS) annual scientific meeting.
“The two-year data for the Xeltis devices are very impressive,” said Thierry Carrel, M.D., Professor of Surgery at the Clinic for Cardiovascular Surgery, University Hospital Bern (Switzerland). “Ultrasound and MRI examinations have demonstrated anatomical and functional stability in all patients after two years, when Xeltis implant will have been gradually absorbed in the body and functionality replaced by components of native tissue formed within and around the implant.”
View the full press release here.